GlaxoSmithKline appointed Andrew Witty to succeed Jean-Pierre Garnier as CEO. He took over in may. Witty has spent his entire career at Glaxo, with stints in South Africa, the U.S., and Asia. He was previously president of the company's European pharma division.

Related Articles:
Just who is Glaxo's Andrew Witty? [1]
GSK chief elaborates on biotech strategy [2]
Witty: Diversifying and de-risking GSK [3]
Consensus: GSK's Witty faces uphill slog [4]
Just who is Glaxo's Andrew Witty? [5]
GSK taps Witty as next CEO [6]